Dr. Kandzari is Chief, Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology of the Piedmont Heart Institute; and Chief Scientific Officer, Piedmont Healthcare in Atlanta, Georgia. Dr. Kandzari specializes in cardiovascular disease, peripheral arterial disease and interventional cardiology. As leader of the Heart Institute, Dr. Kandzari’s areas of focus include innovation and research, enhancing quality of care, provider education and promotion of diversity in healthcare delivery.

Following medical education and training at Duke University School of Medicine and The John Hopkins University School of Medicine, Dr. Kandzari joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. He also served as Chief Medical Officer for the Cordis Corporation/Johnson & Johnson and is the former Director of Interventional Cardiology Research at the Scripps Clinic. In addition, he has served as a Medical Officer for the Center for Devices and Radiological Health for the US FDA. Board certified in Cardiovascular Disease and Interventional Cardiology, Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 400 studies, book chapters and scientific reviews, and has delivered more than 800 lectures, both nationally and internationally, related to both interventional and general cardiology.

Dr. Kandzari has been elected as a Master in the Society of Coronary Angiography and Interventions and is peer-nominated in the top 1% of cardiologists by U.S News and World Report.